Potential Molecular Biomarkers of Preeclampsia-A Pilot Study

Area of Science:

• Obstetrics and Gynecology
• Nephrology
• Biomarker Discovery

Background:

• Preeclampsia is a major cause of maternal and fetal complications, with unclear origins.
• Early identification and monitoring of preeclampsia are crucial for improving outcomes.

Purpose of the Study:

• To identify novel molecular markers for preeclampsia.
• To assess the potential of kidney injury biomarkers in preeclamptic pregnancies.

Main Methods:

• Analyzed serum and urine protein concentrations in 51 preeclampsia patients and 25 healthy controls.
• Utilized Bio-Plex Kidney Toxicity 1 assay, magnetic separation, and flow cytometry.
• Measured six serum biomarkers and urinary proteins.

Main Results:

• Five serum biomarkers (calbindin 1, clusterin, GSTP1, MCP-1, KIM-1) were elevated in preeclampsia patients.
• Serum levels of calbindin 1, clusterin, GSTP1, and KIM-1 were higher in both early and late-onset preeclampsia.
• Urinary KIM-1 was elevated only in late-onset preeclampsia.

Conclusions:

• Maternal plasma concentrations of calbindin 1, clusterin, GSTP1, KIM-1, and MCP-1 show promise as biomarkers for monitoring kidney injury in preeclampsia.
• These findings lay the groundwork for further research into preeclampsia and renal injury biomarkers.